PF-5274857 freebase
CAS No. 1373615-35-0
PF-5274857 freebase ( PF-5274857 | PF 5274857 | PF5274857 )
产品货号. M23528 CAS No. 1373615-35-0
PF-5274857 是一种有效的选择性刺猬信号通路抑制剂(IC50:5.8 nM,Ki:4.6 nM)。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥730 | 有现货 |
|
| 10MG | ¥1007 | 有现货 |
|
| 25MG | ¥1665 | 有现货 |
|
| 50MG | ¥2446 | 有现货 |
|
| 100MG | ¥3384 | 有现货 |
|
| 200MG | ¥4842 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥725 | 有现货 |
|
生物学信息
-
产品名称PF-5274857 freebase
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PF-5274857 是一种有效的选择性刺猬信号通路抑制剂(IC50:5.8 nM,Ki:4.6 nM)。
-
产品描述PF-5274857 is an effective and selective hedgehog signaling pathway inhibitor (IC50: 5.8 nM and a Ki: 4.6 nM). PF-5274857 is a potentially attractive clinical candidate for the treatment of tumor types including brain tumors and brain metastasis driven by an activated Hh pathway.PF-5274857 was found to effectively penetrate the blood-brain barrier and inhibit Smo activity in the brain of primary medulloblastoma mice, resulting in improved animal survival rates. PF-5274857 was orally available and metabolically stable in vivo.
-
体外实验PF-5274857 completely inhibits Shh-induced Hh pathway activity with an IC50 of 2.7±1.4 nM measured by the transcriptional activity of Smo downstream gene Gli1 in MEF cells.PF-5274857 shows less than 20% inhibition against a broad panel of protein kinases at 1 μM.
-
体内实验PF-5274857 (1-30 mg/kg; p.o. once daily for 6 days) shows robust antitumor efficacy and correlation between PK and PD in medulloblastoma allograft mice models.PF-5274857 (10 mg/kg; i.h.) in the plasma is able to cross the blood-brain barrier in rats within 4 hours postdose.PF-5274857 (10-100 mg/kg; p.o. once daily for 4 days) is able to target Smo in the brain leading to the downregulation of Hh pathway activity in the brain tumor.PF-5274857 (30 mg/kg; p.o. once daily for 34 days) increases the survival rates of primary Ptch+/? p53?/? medulloblastoma mice.PF-5274857 (5-30 mg/kg; p.o.) exhibits the apparent volume of distribution of 5.6±0.5 L/kg and the half-life (T1/2) of 1.7±0.1 hours. Animal Model:Severe combined immunodeficient (SCID)-beige mice (6-8 weeks old) are genetically engineeredDosage:0, 1, 5, 10, 30 mg/kgAdministration:P.o. once daily for 6 days Result:Showed robust antitumor activity with an in vivo IC50 of 8.9±2.6 nM.Animal Model:Severe combined immunodeficient (SCID)-beige mice (6-8 weeks old)Dosage:0, 5, 10, 30 mg/kg (Pharmacokinetic Analysis)Administration:A single p.o.Result:The apparent volume of distribution of 5.6±0.5 L/kg; the half-life (T1/2) of 1.7±0.1 hours.
-
同义词PF-5274857 | PF 5274857 | PF5274857
-
通路Wnt/Notch/Hedgehog
-
靶点Smoothened (Smo)
-
受体smo
-
研究领域——
-
适应症——
化学信息
-
CAS Number1373615-35-0
-
分子量436.96
-
分子式C20H25ClN4O3S
-
纯度>98% (HPLC)
-
溶解度DMSO:125 mg/mL?(286.07 mM;?Need ultrasonic)
-
SMILESCC1=CC(=C(N=C1)C2=CC(=NC=C2Cl)N3CCN(CC3)C(=O)CCS(=O)(=O)C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Zhou WJ, Chen J, Feng Y, Fan YP, Li Q, Fu J, Zhang P. [Inhibition of Cigarettes Smoke-induced Epithelial to Mesenchymal Transition by the SMO Inhibitor PF-5274857 in Beas-2b Epithelial Cells]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2016 Jul;47(4):485-490. Chinese. PubMed PMID: 28591947.
021-51111890
购物车()
sales@molnova.cn

